Home >Documents >2015 ANNUAL INFORMATION FORM 2018-11-27¢  Concordia Healthcare Corp. 3 2015 Annual...

2015 ANNUAL INFORMATION FORM 2018-11-27¢  Concordia Healthcare Corp. 3 2015 Annual...

Date post:28-Dec-2019
Category:
View:0 times
Download:0 times
Share this document with a friend
Transcript:
  • 2015 ANNUAL INFORMATION FORM

    MARCH 23, 2016

  • TABLE OF CONTENTS

    EXPLANATORY NOTES ...................................................................................................................................... 3 Glossary ....................................................................................................................................................................................................... 3 Trademarks .................................................................................................................................................................................................. 3 Currency ....................................................................................................................................................................................................... 3 Market Data................................................................................................................................................................................................. 3

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION.............................................. 4

    CORPORATE STRUCTURE ................................................................................................................................. 6 Name, Address and Incorporation ......................................................................................................................................................... 6 Governance ................................................................................................................................................................................................. 6 Intercorporate Relationships ................................................................................................................................................................... 6

    GENERAL DEVELOPMENT OF THE BUSINESS ............................................................................................ 7

    DESCRIPTION OF THE BUSINESS .................................................................................................................. 12

    COMPETITION .................................................................................................................................................... 13

    CONCORDIA INTERNATIONAL ...................................................................................................................... 14 Overview .................................................................................................................................................................................................... 14 Products ..................................................................................................................................................................................................... 14 Product Development and Production ............................................................................................................................................... 16 Sales and Distribution ............................................................................................................................................................................. 17 Key Markets, Growth and Marketing Strategy................................................................................................................................... 17 United Kingdom ...................................................................................................................................................................................... 18 Intellectual Property Matters ................................................................................................................................................................. 19 Regulatory Matters ................................................................................................................................................................................... 19 Launch of New Products ....................................................................................................................................................................... 19

    CONCORDIA NORTH AMERICA ..................................................................................................................... 20 Overview .................................................................................................................................................................................................... 20 Products ..................................................................................................................................................................................................... 20 Product Development and Production ............................................................................................................................................... 21 Sales and Distributions............................................................................................................................................................................ 21 Key Markets, Growth and Marketing Strategy................................................................................................................................... 22 Intellectual Property Matters ................................................................................................................................................................. 24 Regulatory Matters ................................................................................................................................................................................... 24 Reorganization .......................................................................................................................................................................................... 25

    ORPHAN DRUGS ................................................................................................................................................ 26 Overview .................................................................................................................................................................................................... 26 Market Overview ...................................................................................................................................................................................... 26 PDT with Photofrin® ............................................................................................................................................................................. 27 Existing Indications ................................................................................................................................................................................. 27 New Indications ....................................................................................................................................................................................... 27 Special Protocol Assessment ................................................................................................................................................................. 28 Other Developments ............................................................................................................................................................................... 28 Post-Acquisition Value Added by Orphan Drugs ............................................................................................................................. 28

    REPORTABLE SEGMENT SUMMARY TABLE................................................................................................ 29

    DIVIDEND POLICY ............................................................................................................................................ 29

    DESCRIPTION OF CAPITAL STRUCTURE ..................................................................................................... 30 Common Shares ....................................................................................................................................................................................... 30 Stock Option Plan .................................................................................................................................................................................... 30 Long Term Incentive Plan ..................................................................................................................................................................... 31

    RATINGS .............................................................................................................................................................. 34 S&P ............................................................................................................................................................................................................. 35 Moody’s ...................................................................................................................................................................................................... 35

    MARKET FOR SECURITIES .............................................................................................................................. 35 Trading Price and Volume ..................................................................................................................................................................... 35 Prior Sales ...............................................................

Click here to load reader

Embed Size (px)
Recommended